ACE2 and infection: Higher levels of RBD-ACE2 binding inhibition (median 20.9%) were demonstrated in participants with both vaccination and previous SARS-CoV-2 infection (evidenced by anti-N positivity) than those with either vaccination or infection alone, suggesting a greater degree of humoral immune protection in this subgroup.